TREM2 and Alzheimer disease: According to our bibliometric analysis, the most concerned AD pathogenesis and current research hotspots were (1) Aβ and tau, (2) immunity and microglia, with TREM2 as a potential immunotherapy target, and (3) DNA methylation.